Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients

AUTOR(ES)

Ives, Natalie J

FONTE

BMJ Publishing Group Ltd.

RESUMO

Objective To quantify more reliably the benefits and risks of monoamine oxidase type B inhibitors (MAOBIs) in early Parkinson's disease.

Documentos Relacionados

• Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials
• Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials
• Using monoamine oxidase type B inhibitors in Parkinson's disease: They are effective and safe, at least when used alone
• Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials
• Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials